Imodium Melt Tablets 2 mg Orodispersible tablets
PDF Leaflet Revision Date: 28 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Control and symptomatic relief of acute and chronic non-specific diarrhoea.
Dosage (summary)
Adults: 2 tablets initially, then 1 after each loose stool. Max 8 tablets/day. Children 6-12 years: 1 tablet initially, then 1 after each loose stool.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; not recommended during breastfeeding.
Key Drug Interactions
- Quinidine
- Ritonavir
- Itraconazole
- Gemfibrozil
- Ketoconazole
Contraindications
- Hypersensitivity to loperamide
- Children under 6 years
- Acute dysentery
- Acute ulcerative colitis
- Bacterial enterocolitis
- Pseudomembranous colitis
Common side effects
- Constipation
- Flatulence
- Headache
- Nausea
- Dizziness
Counselling Points
- Stop if no improvement in 48 hours
- Use caution when driving
- Report any severe side effects
Serious warnings
- CNS toxicity risk in hepatic impairment
- Risk of toxic megacolon in AIDS patients
- QT prolongation in overdose
Important Disclaimer
The Imodium Melt Tablets 2 mg Orodispersible tablets professional information leaflet below is the property of Johnson & Johnson and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
